UAB "Centralpharma Communications" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 125,000 |
| 50,201 |
| 1,589 |
| 1,509 |
| 606 |
| 76.95 |
| 1.21 |
| 23,506 |
| 2,837 |
| 220 |
| 25,597 |
| 2023 |
|---|
| 121,500 |
| 40,500 |
| 1,073 |
| 1,019 |
| 340 |
| 89.01 |
| 0.84 |
| 24,525 |
| 2,651 |
| 89 |
| 26,878 |
| 2024 |
|---|
| 207,500 |
| 56,081 |
| 441 |
| 416 |
| 112 |
| 89.35 |
| 0.20 |
| 24,941 |
| 4,299 |
| 947 |
| 27,951 |
Register and
explore Okredo data| 2024 |
|---|
| 207,500 |
| 56,081 |
| 441 |
| 416 |
| 112 |
| 89.35 |
| 0.20 |
| 24,941 |
| 4,299 |
| 947 |
| 27,951 |
Register and
explore Okredo data2024
Turnover (€)
207,500 €
71 % *
Sales per employee (€)
56,081 €38 % *
Profit before tax (€)
441 €
-59 % *
Net Profit (€)
416 €-59 % *
Profit per employee (€)
112 €-67 % *
Total profitability (%)
89.35 %0.38 % *
Net profitability (%)
0.20 %-76.19 % *
Equity (€)
24,941 €2 % *
Amounts Payable And Liabilities (€)
4,299 €
62 % *
Non-current Assets (€)
947 €964 % *
CurrentAssets (€)
27,951 €4 % *